Erratum for the Research Article: A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent (Science Translational Medicine DOI: 10.1126/scitranslmed.aah4807)

N. Gioelli, F. Maione, C. Camillo, M. Ghitti, D. Valdembri, N. Morello, M. Darche, L. Zentilin, G. Cagnoni, Y. Qiu, M. Giacca, M. Giustetto, M. Paques, I. Cascone, G. Musco, L. Tamagnone, E. Giraudo, G. Serini

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Research Article “A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent,” the right panel graph of Fig. 5D (siNRP1) was erroneously duplicated in the left panel (siCtl). However, correct experimental values were reported in table S4 (provided as an Excel le) that contains raw data relating to both siCtl and siNRP1 panels of Fig. 5D. The left panel of Fig. 5D has been replaced so that it now contains a graph plotted with correct siCtl values, as originally displayed in table S4. This error does not change the ndings or conclusions of the study. The PDFs and HTML (full text) have been corrected.

Original languageEnglish
Article numbereaau7326
JournalScience Translational Medicine
Volume10
Issue number451
DOIs
Publication statusPublished - 23 May 2018

Fingerprint

Dive into the research topics of 'Erratum for the Research Article: A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent (Science Translational Medicine DOI: 10.1126/scitranslmed.aah4807)'. Together they form a unique fingerprint.

Cite this